SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Satchel Paige

PatientSatchel Paige
Date of birth1953-07-07
IdentifiersMRN HR-ML047-SYN; SSN (made up) 000-47-3381
Document date2026-09-22
AuthorDelphine Whitaker-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

More breathless, with more and greener sputum, for three days after a cold. [S]

History of Present Illness

Mr. Paige called the clinic this morning, as his action plan says to when his symptoms worsen, and was seen the same day. A cold went around his church two weeks ago; five days ago he had a runny nose and sore throat, and for three days he has been more breathless than usual, now after half a block, with more sputum that has turned from clear to green and wheeze at night. He has used his albuterol four to five times a day, which helps for a few hours. He has taken his umeclidinium-vilanterol every morning. His home temperature was 37.8 °C last night. He has no chest pain, no blood in the sputum, no leg swelling and no new orthopnea. He is not smoking. He missed his two rehabilitation sessions this week. A home rapid test for COVID-19 and influenza was negative yesterday. [S]

ElementDetail
OnsetThree days ago, two days after a cold began
SeverityBreathless after half a block (worse than his usual one block); speaking in full sentences
ContextCOPD on a LAMA with a LABA; no exacerbation in the past year
Associated signs and symptomsMore sputum, now green; wheeze at night; temperature to 37.8 °C; no chest pain, hemoptysis or leg swelling
Modifying factorsAlbuterol helps for a few hours

Review of Systems

SystemResultFinding
ConstitutionalPositiveLow-grade temperature; tired; no rigors
Ears, nose, mouth, and throatPositiveRunny nose and sore throat, settling
RespiratoryPositiveMore breathlessness, more and green sputum, night wheeze; no hemoptysis
CardiovascularNegativeNo chest pain, palpitations, orthopnea or ankle swelling

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessnessTwo inhalations with a spacer every 4 hours as neededRespiratory tract route2026-07-14activeS
Umeclidinium 62.5 micrograms with vilanterol 25 micrograms dry powder inhaler (a LAMA with a LABA), one inhalation once a dayOne inhalation each morning; a strong, deep breath inRespiratory tract route2026-07-28activeS
Atorvastatin 20 mg tablet once a dayOne tablet each eveningOral route2026-07-14activeS
Prednisone 40 mg (two 20 mg tablets) by mouth each morning for five daysTwo tablets each morning with food for five daysOral route2026-09-22 to 2026-09-26completedS
Doxycycline 100 mg capsule by mouth twice a day for five daysOne capsule twice a day with a full glass of water, sitting up, for five daysOral route2026-09-22 to 2026-09-26completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-22Body height191cmS
2026-09-22Body weight82.2kgS
2026-09-22Body mass index (BMI) [Ratio]22.5kg/m2S
2026-09-22Systolic blood pressure134mm[Hg]S
2026-09-22Diastolic blood pressure80mm[Hg]S
2026-09-22Heart rate96/minS
2026-09-22Respiratory rate22/minS
2026-09-22Body temperature37.5CelS
2026-09-22Oxygen saturation in Arterial blood by Pulse oximetry92%S

Physical Exam

Vital signs recorded on 2026-09-22; see the Vital Signs section. [S]

SystemFinding
GeneralMildly breathless at rest, speaking in full sentences; no use of accessory muscles; not confused
Vital signsTemperature 37.5 °C; pulse 96; respiratory rate 22; blood pressure 134/80; oxygen saturation 92 percent on room air, from his usual 94 to 95
RespiratoryProlonged expiration with scattered wheeze on both sides; no crackles or bronchial breathing; good air entry
CardiovascularRegular rhythm; no murmur; no raised jugular venous pressure; no leg edema
Ears, nose, mouth, and throatMildly red throat; no exudate

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultationresolvedconfirmed R06.09S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD.
Chronic obstructive pulmonary disease, GOLD grade 2 (post-bronchodilator FEV1/FVC 0.58, FEV1 61% predicted by the race-neutral GLI Global equations), GOLD group B (CAT 18, mMRC 2, no exacerbation in the past year); alpha-1 antitrypsin normal; blood eosinophils 0.08 x 10^3/uL; synthetic modern diagnosis linked to his documented emphysemaactiveconfirmed J44.9S — Synthetic modern diagnosis made at the consultation, anchored to his documented emphysema; its onset and course in the modern episode are synthetic.
Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use sinceactiveconfirmed Z87.891S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such.
Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decisionactiveconfirmed E78.5S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids.
Moderate exacerbation of COPD with a viral cold: more breathlessness, more sputum turning green, and wheeze for three days; oxygen saturation 92 percent; no pneumonia on chest X-ray; treated at home with prednisone and doxycycline; recoveredactiveconfirmed J44.1S — Synthetic exacerbation at the sick visit; not a historical claim.

Assessment and Plan

Guideline basis: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Racial Bias in Pulse Oximetry Measurement (2020)

Follow-up: Review at the wellness visit in two weeks, or sooner as above. Next scheduled visit 2026-10-06: subsequent annual wellness visit. [S]